Voyager Therapeutics (VYGR) PT Lowered to $8 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Voyager Therapeutics (VYGR) Tops Q1 EPS by 24c, provides guidance
May 13, 2024 4:23 PM EDTVoyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of ($0.20), $0.24 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $9.42 million.
Financial Guidance
Voyager is committed to maintaining a strong balance sheet that... More



